Kalaris Therapeutics Stock (NASDAQ:KLRS)
Previous Close
$6.10
52W Range
$2.14 - $11.88
50D Avg
$7.82
200D Avg
$6.26
Market Cap
$114.27M
Avg Vol (3M)
$67.45K
Beta
0.18
Div Yield
-
KLRS Company Profile
Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.